SCHOTT
Develops and supplies specialty glass and glass-ceramic materials for additive manufacturing, including NEXTREMA® series for 3D printing applications.
- CEO / Founder
- Dr. Torsten Derr
- Team Size
- 10000+
- Stage
- Active
- Latest Round
- Bootstrapped
Technology & Products
Key Products
SCHOTT develops and supplies specialty glass and glass-ceramic materials, including NEXTREMA® series for 3D printing, architecture and processed glasses, and drug containment solutions (SCHOTT Pharma).
Technological Advantage
VERIFIED: Industry-leading glass-ceramic technology with high thermal/chemical resistance; DEFENSIBLE through trade secrets and material patents. CLAIMED: Customized material solutions for AM applications.
Differentiation
Value Proposition
Provides high-quality, customized glass-ceramic materials that enable precise, durable 3D-printed parts with superior thermal and chemical resistance, reducing prototyping costs and accelerating product development.
How They Differentiate
Specializes in glass-ceramics for AM with NEXTREMA® series, offering higher thermal resistance (up to 800°C) and chemical durability vs. standard ceramics, backed by decades of material science expertise.
Market & Competition
Target Customers
Aerospace, medical, photonics, and industrial manufacturers using AM for high-performance components.
Industry Verticals
Aerospace; Medical; Industrial; Photonics
Competitors
AGC Group, Corning Inc., Gerresheimer, Asahi Kasei, NSG Group.
Growth & Milestones
Growth Metrics
Revenue nearly maintained at EUR 2.8 billion in challenging market; SCHOTT Pharma EBITDA grew 9% YoY to EUR 239m in 2023.
Major Milestones
Founded in 1884; IPO of SCHOTT Pharma in 2023 raising €813 million; Expansion into AM materials with NEXTREMA® series
Notable Customers
Aerospace/defense companies (e.g., for radomes and antenna components), medical device manufacturers (e.g., for dental restorations and implants), automotive suppliers (e.g., for sensors and lighting), electronics companies (e.g., for semiconductor packaging)